Evidence for Enhanced Exosome Production in Aromatase Inhibitor-Resistant Breast Cancer Cells

Aromatase inhibitors (AIs) represent the standard anti-hormonal therapy for post-menopausal estrogen receptor-positive breast cancer, but their efficacy is limited by the emergence of AI resistance (AI(R)). Exosomes act as vehicles to engender cancer progression and drug resistance. The goal of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Augimeri, Giuseppina, La Camera, Giusi, Gelsomino, Luca, Giordano, Cinzia, Panza, Salvatore, Sisci, Diego, Morelli, Catia, Győrffy, Balázs, Bonofiglio, Daniela, Andò, Sebastiano, Barone, Ines, Catalano, Stefania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461508/
https://www.ncbi.nlm.nih.gov/pubmed/32823947
http://dx.doi.org/10.3390/ijms21165841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461508/
https://www.ncbi.nlm.nih.gov/pubmed/32823947
http://dx.doi.org/10.3390/ijms21165841

Ejemplares similares